Axsome Therapeutics, Inc. (AXSM)
189.10
+4.60
(+2.49%)
USD |
NASDAQ |
Jan 21, 16:00
189.01
-0.09
(-0.05%)
After-Hours: 20:00
Axsome Therapeutics Market Cap: 9.533B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.819B |
| Gilead Sciences, Inc. | 160.18B |
| Vanda Pharmaceuticals, Inc. | 468.64M |
| Amicus Therapeutics, Inc. | 4.427B |
| MannKind Corp. | 1.753B |
Market Cap Related Metrics
| PS Ratio | 16.58 |
| Price to Book Value | 129.30 |
| Price | 189.10 |
| Earnings Yield | -2.47% |